Acute migraine treatment focuses on managing symptoms when an attack occurs. Zavzpret provides one modern option for adults who need acute treatment for migraine with or without aura. As a CGRP receptor antagonist delivered through a nasal spray, it works differently from several older migraine treatment approaches.
Acute migraine medicines are generally used when migraine symptoms occur, with the goal of treating the attack rather than preventing future episodes.
Zavzpret belongs to the CGRP antagonist class and works by blocking CGRP receptors.
Its main characteristics include:
Not every migraine treatment works in the same way for every person. A healthcare professional may consider previous treatment experiences and the characteristics of a person's migraine before selecting an appropriate option.
Useful topics for discussion include:
Keeping a record of migraine attacks may also help healthcare professionals understand patterns and make more informed treatment decisions.
Zavzpret is part of the expanding range of acute migraine treatments available to adults. Its CGRP receptor mechanism and nasal delivery distinguish it from many conventional approaches. Professional guidance is important when evaluating whether it is suitable for an individual's migraine management needs.